(Q35819316)

10 August 2017

Development of a castrate resistant transplant tumor model of prostate cancer (English)

1 reference

10 August 2017

1 reference

Leigh Ellis

1

1 reference

10 August 2017

Kristin Lehet

2

1 reference

10 August 2017

Swathi Ramakrishnan

3

1 reference

10 August 2017

Remi Adelaiye

4

1 reference

10 August 2017

Roberto Pili

5

1 reference

10 August 2017

27 July 2011

1 reference

10 August 2017

1 reference

10 August 2017

72

1 reference

10 August 2017

6

1 reference

10 August 2017

587-591

1 reference

Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

The current state of preclinical prostate cancer animal models

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

Molecular determinants of resistance to antiandrogen therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298731

24 September 2018

Identifiers

DOI

10.1002/PROS.21465

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

21796655

1 reference